Gephyrin Suppresses Lung Squamous Cell Carcinoma Development by Reducing mTOR Pathway Activation
Cancer Management and Research - New Zealand
doi 10.2147/cmar.s204358
Full Text
Open PDFAbstract
Available in full text
Categories
Date
June 1, 2019
Authors
Publisher
Informa UK Limited